Description
Deferasirox Tablet DT
Deferasirox was approved by the U.S. Food and Drug Administration (FDA) in November 2005. According to the FDA (May 2007), kidney failure and cytopenias have been reported in patients receiving deferasirox tablets for oral suspension. It is approved in the European Union by the European Medicines Agency (EMA) for children six years and older for chronic iron overload from repeated blood transfusions. It is on the World Health Organization’s List of Essential Medicines.
List Of Generic Brands For Deferasirox Tablet DT In India
If you are looking generic brands for Deferasirox Tablet DT in India. Please contact us at +91 9953466646 or drop us an email at sales@aarkpharma.com. Our representatives will be happy to assist you and answer any questions you may have Deferasirox Tablet Price is available at Aark Pharmaceuticals.